menu
    • menu
    [{"orgOrder":0,"company":"Aenova Group","sponsor":"Immunic Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Vidofludimus Calcium","moa":"DHODH | NR4A2 | NRBP1","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Aenova Group","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Aenova Group \/ Immunic Therapeutics","highestDevelopmentStatusID":"8","companyTruncated":"Aenova Group \/ Immunic Therapeutics"},{"orgOrder":0,"company":"Aenova Group","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"GERMANY","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Seaweed Extract","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Approved FDF","graph3":"Aenova Group","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Softgel Capsule","sponsorNew":"Aenova Group \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Aenova Group \/ Undisclosed"},{"orgOrder":0,"company":"Aenova Group","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Microbiota","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Aenova Group","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Aenova Group \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Aenova Group \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Aenova Group

    Menu

    Aenova Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Aenova Group

                            Germany
                            Pharmapack
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothTrusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Gastroenterology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            New Probiotic Softgel Capsules Support Gut Flora Health

                            Details : An undisclosed probiotic targeting microbiota is showing promising results in treating gastrointestinal disorders.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            October 25, 2021

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Aenova Group

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Aenova Group

                            Germany
                            Pharmapack
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothTrusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

                            Lead Product(s) : Seaweed Extract

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            New Chewable VegaGels® with Algae-Based Omega-3 in Multiple Colors and Flavors

                            Details : Seaweed Extract, a plant extract/herbal product, shows promising results in treating undisclosed Key Focus Area.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            September 23, 2021

                            Lead Product(s) : Seaweed Extract

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Aenova Group

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Aenova Group

                            Germany
                            Pharmapack
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothTrusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

                            Lead Product(s) : Vidofludimus Calcium

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II

                            Sponsor : Immunic Therapeutics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Covid-19: Phase 2 Trial Begins for IMU-838

                            Details : Vidofludimus Calcium, a miscellaneous product, targets DHODH, NR4A2, and NRBP1 to address undisclosed key focus areas in biomedical research.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 27, 2020

                            Lead Product(s) : Vidofludimus Calcium

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II

                            Sponsor : Immunic Therapeutics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Aenova Group

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.